On November 15, 2012, CCL Senior Litigation Counsel Louis Bograd spoke at a mass torts seminar at the Ohio Association for Justice Mid-Winter meeting in Cleveland. Bograd’s speech, entitled Drug and Device Litigation: Understanding and Coping with the Supreme Court's Evolving Preemption Jurisprudence, reviewed the Supreme Court’s preemption jurisprudence over the past two decades with particular regard to its application to products liability claims against the manufacturers of products regulated by the FDA including medical devices, prescription and non-prescription drugs, and vaccines. Bograd advised the audience that attorneys litigating products liability and consumer protection claims involving products regulated by the FDA need to understand the reach and limits of the doctrine of FDA preemption as it applies to each regulated product.